Your browser doesn't support javascript.
loading
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.
Roumier, Mathilde; Paule, Romain; Vallée, Alexandre; Rohmer, Julien; Ballester, Marie; Brun, Anne-Laure; Cerf, Charles; Chabi, Marie-Laure; Chinet, Thierry; Colombier, Marie-Alice; Farfour, Eric; Fourn, Erwan; Géri, Guillaume; Khau, David; Marroun, Ibrahim; Ponsoye, Matthieu; Roux, Antoine; Salvator, Hélène; Schoindre, Yoland; Si Larbi, Anne-Gaëlle; Tchérakian, Colas; Vasse, Marc; Verrat, Anne; Zuber, Benjamin; Couderc, Louis-Jean; Kahn, Jean-Emmanuel; Groh, Matthieu; Ackermann, Félix.
Afiliación
  • Roumier M; Department of Internal Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Paule R; Department of Internal Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Vallée A; Diagnosis and Therapeutic Center, Hypertension and Cardiovascular Prevention Unit, AP-HP, Hôtel-Dieu Hospital, Paris-Descartes University, Paris, France.
  • Rohmer J; Department of Internal Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Ballester M; Emergency Department, Foch Hospital, F-92151, Suresnes, France.
  • Brun AL; Department of Radiology, Foch Hospital, F-92151, Suresnes, France.
  • Cerf C; Department of Anesthesiology and Intensive Care, Foch Hospital, F-92151, Suresnes, France.
  • Chabi ML; Department of Radiology, Foch Hospital, F-92151, Suresnes, France.
  • Chinet T; Department of Respiratory Medicine, Ambroise Paré Hospital, AP-HP, F-92100, Boulogne-Billancourt, France.
  • Colombier MA; Simone Veil Medical Faculty, Université Paris-Saclay, Montigny-le-Bretonneux, France.
  • Farfour E; Department of Internal Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Fourn E; Department of Clinical Biology & INSERM UMRS-1176, Foch Hospital, F-92151, Suresnes, France.
  • Géri G; Department of Internal Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Khau D; Simone Veil Medical Faculty, Université Paris-Saclay, Montigny-le-Bretonneux, France.
  • Marroun I; Medical Intensive Care Unit, Ambroise Paré Hospital, AP-HP, F-92100, Boulogne-Billancourt, France.
  • Ponsoye M; INSERM UMR 1018, Villejuif, France.
  • Roux A; Department of Internal Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Salvator H; Department of Internal Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Schoindre Y; Department of Internal Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Si Larbi AG; Simone Veil Medical Faculty, Université Paris-Saclay, Montigny-le-Bretonneux, France.
  • Tchérakian C; Department of Respiratory Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Vasse M; Simone Veil Medical Faculty, Université Paris-Saclay, Montigny-le-Bretonneux, France.
  • Verrat A; Department of Respiratory Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Zuber B; Department of Internal Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Couderc LJ; Department of Anesthesiology and Intensive Care, Foch Hospital, F-92151, Suresnes, France.
  • Kahn JE; Department of Respiratory Medicine, Foch Hospital, F-92151, Suresnes, France.
  • Groh M; Department of Clinical Biology & INSERM UMRS-1176, Foch Hospital, F-92151, Suresnes, France.
  • Ackermann F; Emergency Department, Foch Hospital, F-92151, Suresnes, France.
J Clin Immunol ; 41(2): 303-314, 2021 02.
Article en En | MEDLINE | ID: mdl-33188624
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: Anticuerpos Monoclonales Humanizados / SARS-CoV-2 / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Immunol Año: 2021 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: Anticuerpos Monoclonales Humanizados / SARS-CoV-2 / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Immunol Año: 2021 Tipo del documento: Article País de afiliación: Francia